and weight loss, and we look forward to additional data readouts later this year," David A. Ricks, Lilly's chair and CEO, said. "As a convenient once-daily pill, orforglipron may provide a new ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

A new GLP-1 pill from Eli Lilly has ... GLP-1 pill data to the FDA by the end of the year for consideration of the pill for weight loss management, and for Type 2 diabetes management in early ...

Orforglibron, a pill form of GLP-1 weight loss injections like Ozempic and ... the U.S. Food and Drug Administration later this year to offer orforglipron for obesity, and early next year for ...

Femme Viva+ offers a convenient solution that can be integrated into busy lifestyles, helping them achieve their weight loss goals without ... with my weight for years, and Femme Viva+ has been ...

According to early clinical trial results shared on Thursday, a new pill may offer blood sugar-lowering and weight-loss effects of ... later this year. They plan to market orforglipron for obesity ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

But this one, for Lilly’s first diabetes and weight-loss pill ... 2024 from its new gene therapy, which helped a deaf boy hear again. All of this has made Lilly, at nearly 150 years old, the ...